FDA Recall Open, Classified

In-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit, REF 01N15-010; (2) Abbott Vysis LSI D13S319 (13q14.3) SpectrumOrange Probe, REF 01N34-020;

Recall: Z-1188-2024 · Initiated February 1, 2024

Recall

Recall Number
Z-1188-2024
Event Number
93902
Firm
Abbott Molecular, Inc.
FEI Number
3005248192
Product Code
OYU
Status
Open, Classified
Root Cause
Process control
Initiated
February 1, 2024
Posted
February 26, 2024
Address
1300 E Touhy Ave, Des Plaines, IL, 60018-3315

Description

In-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit, REF 01N15-010; (2) Abbott Vysis LSI D13S319 (13q14.3) SpectrumOrange Probe, REF 01N34-020;

Reason

Products that were intended for export only which were not approved or registered in accordance with U.S. specifications were shipped to U.S. customers.

Action

The recalling firm issued letters dated and issued on 2/1/2024 via FedEx priority overnight express mail. The letter explained the background, potential impact, and necessary actions to be taken and contained an appendix listing Impacted Abbott Products and an appendix listing CE products and similar US products. The actions to be taken were to destroy all remaining inventory of the impacted products and contact their local Abbott representative for replacements. If the product has been forwarded to other laboratories, the consignee is requested to inform them of the recall and have them take the necessary actions. The letter states that laboratories should follow internal procedures in regard to a lookback of results and a lookback should be considered if results have been released that are tied to performance claims. A Customer Reply Form was enclosed to acknowledge receipt of the letter. The consignee was to record the amount of affected product that was destroyed.

Distribution

US Nationwide distribution in the states of AL, CA, IL, MA, MD, MN, NY, and PA.

Quantity

16 kits